Your browser is no longer supported. Please, upgrade your browser.
VAPO Vapotherm, Inc. daily Stock Chart
Vapotherm, Inc.
Index- P/E- EPS (ttm)-2.55 Insider Own32.00% Shs Outstand18.68M Perf Week0.05%
Market Cap373.79M Forward P/E- EPS next Y-2.55 Insider Trans- Shs Float10.84M Perf Month16.40%
Income-42.50M PEG- EPS next Q-0.78 Inst Own75.00% Short Float2.16% Perf Quarter18.40%
Sales42.40M P/S8.82 EPS this Y-34.40% Inst Trans64.90% Short Ratio4.58 Perf Half Y-
Book/sh3.06 P/B6.54 EPS next Y9.90% ROA- Target Price26.33 Perf Year-
Cash/sh0.71 P/C28.32 EPS next 5Y- ROE- 52W Range14.70 - 22.29 Perf YTD0.30%
Dividend- P/FCF- EPS past 5Y- ROI27.50% 52W High-10.23% Beta-
Dividend %- Quick Ratio1.90 Sales past 5Y- Gross Margin39.60% 52W Low36.12% ATR1.08
Employees298 Current Ratio3.00 Sales Q/Q19.00% Oper. Margin-82.50% RSI (14)55.58 Volatility6.59% 5.80%
OptionableNo Debt/Eq- EPS Q/Q-23.50% Profit Margin-86.90% Rel Volume1.09 Prev Close22.17
ShortableYes LT Debt/Eq- EarningsMar 12 AMC Payout- Avg Volume51.05K Price20.01
Recom1.00 SMA202.14% SMA5012.28% SMA20012.00% Volume55,515 Change-9.74%
Dec-10-18Initiated William Blair Outperform
Dec-10-18Initiated Canaccord Genuity Buy $25
Dec-10-18Initiated BofA/Merrill Buy $26
Mar-22-19 05:48PM  Vapotherm Inc (VAPO) Files 10-K for the Fiscal Year Ended on December 31, 2018 -9.74%
Mar-12-19 05:44PM  Vapotherm: 4Q Earnings Snapshot Associated Press
04:13PM  Vapotherm Reports Fourth Quarter and Fiscal Year 2018 Financial Results Business Wire
02:30PM  Vapotherm, Inc. to Host Earnings Call ACCESSWIRE
Feb-13-19 07:30AM  Vapotherm® Releases Next Generation of Capital Unit: Precision Flow Hi-VNI System Business Wire
Dec-24-18 07:30AM  Vapotherm to be Added to the Russell 2000®, 3000® and Microcap® Indexes Business Wire
Dec-04-18 08:00AM  Clinical Study Shows Vapotherms New IntellO2 Module for Precision Flow® System Significantly Improves Maintenance of Premature Neonates in Target Oxygenation Range Business Wire
Nov-16-18 11:58AM  Vapotherm Announces Closing of Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares Business Wire
Nov-14-18 11:08AM  Vapotherm shares soar 8.5% in trading debut MarketWatch
06:58AM  Vapotherm sells 4 million shares priced at $14 each in IPO to raise $56 million MarketWatch
Nov-13-18 08:48PM  Vapotherm Announces Pricing of Initial Public Offering Business Wire
Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary Hi-VNI technology products used to treat patients of various ages suffering from respiratory distress worldwide. The company offers precision flow systems, such as Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that use Hi-VNI technology to deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit and Q50 compressor; and disposable products comprising single-use disposables and nasal interfaces. The company sells its products to hospitals through a direct sales force in the United States; and through distributors in various countries internationally. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.